RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2015 /PRNewswire/ -- Marken announced today the opening of a new operational hub in Boston, Massachusetts. The new hub expands and enhances Marken's capabilities in the US Northeast region by joining the New York and Philadelphia branches. The hub location is conveniently located in Burlington, MA with easy access to Boston's Logan Airport. More importantly, it is located in an area which is home to a major concentration of biopharmaceutical and life science companies.
Speaking on behalf of the company, Mark Hembarsky, Marken's Regional Vice President for North America, said, "We are very pleased to have a new home in Boston. This new hub is already fully functional and handling complex clinical trial materials on behalf of our customers. By adding Boston to our New York and Philadelphia operational centers, we can now serve the entire northeast region from three major gateway airports. We look forward to spending more time with our current clients in the Boston area, as well as introducing Marken to the many biotech companies which are headquartered here."
Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments, and offers a state of the art GMP-compliant depot network and logistic hubs in 43 locations worldwide. Marken's 630 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane qualifications, as well as GDP, regulatory and compliance consultancy add to Marken's unique position in the pharma and logistics industry.